![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 19, 2006 1:28:41 PM
>>> Program#/Poster#: 267.2/GG19
Title: Effects of the positive allosteric AMPA receptor modulator BIIR 777: In vitro and in vivo studies
Location: Georgia World Congress Center: Halls B3-B5
Presentation Start/End Time: Sunday, Oct 15, 2006, 2:00 PM - 3:00 PM
Authors: *T. WEISER1, K. WINTER2, K. KLINDER3, T. OSUGI4, A. CECI1;
1CNS Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GERMANY, 2Quality Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GERMANY, 3Drug Discovery Support, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GERMANY, 4R&D Project Management, Boehringer Ingelheim US, Rigdefield, CT.
Positive modulation of AMPA-receptor mediated neurotransmission is a promising approach for the treatment of disorders affecting learning and memory. Here we describe the effects of BIIR 777, a novel and selective AMPA receptor modulator. In patch-clamp experiments using rat cortical neurons, or cells transfected with human GluR1/2, BIIR 777 significantly reduced desensitisation at concentrations >1 µM without affecting agonist potency. Investigating selectivity in >65 binding assays showed that the compound was highly selective. In anaesthetised rats, the excitatory local effect of AMPA on electrical activity of CA1 pyramidal hippocampal neurons was significantly increased in response to iontophoretic coadministration with BIIR 777. The systemic administration of BIIR 777 increased firing frequencies of pyramidal neurons in the CA1 region of the hippocampus, as well as in prefrontal cortex (CG3; at doses of 0.1 to 0.3 mg/kg i.v.). Pharmakokinetic investigations showed that BIIR 777 was orally available, penetrated the blood-brain barrier well, and had a plasma halflife of 8.5 h after oral administration. Thus, this compound was suitable for further in vivo models of learning and memory. In the passive avoidance test in rats, 30 mg/kg p.o. significantly reduced the proamnesic effect of alprazolam (0.45 mg/kg i.p.). In the rat object recognition test, BIIR 777 significantly augmented memory at 3, 10, and 30 mg/kg p.o.
These data show that BIIR 777 is a potent positive allosteric modulator of AMPA receptor function with promising properties in models of learning and memory in vivo. <<<
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM